Biolife Solutions (BLFS) Cash from Investing Activities (2010 - 2026)

Biolife Solutions (BLFS) has reported Cash from Investing Activities for 17 consecutive years, with -$1.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 93.27% year-over-year to -$1.8 million; the TTM figure through Mar 2026 stood at -$46.2 million (down 247.37% YoY), while the FY2025 annual figure was -$71.5 million, down 222.71% from the prior year.
• Cash from Investing Activities retreated to -$1.8 million in Q1 2026 per BLFS's latest filing, from $1.1 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $73.6 million in Q4 2024 and bottomed at -$39.5 million in Q2 2025.
• Historically, Cash from Investing Activities has averaged -$3.3 million across 5 years, with a median of -$1.8 million in 2026.
• Annual changes were most pronounced in 2024 — Cash from Investing Activities soared 1760.93% — and 2025, when it sank 12196.83%.
• Biolife Solutions' Cash from Investing Activities stood at -$14.9 million in 2022, then soared by 126.57% to $4.0 million in 2023, then jumped by 1760.93% to $73.6 million in 2024, then tumbled by 98.46% to $1.1 million in 2025, then sank by 260.95% to -$1.8 million in 2026.
• Business Quant data shows BLFS's Cash from Investing Activities at -$1.8 million in Q1 2026, $1.1 million in Q4 2025, and -$6.0 million in Q3 2025.